BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6262482)

  • 1. Frequency modulation of the inotropic action of isoproterenol in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):314-25. PubMed ID: 6262482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate dependence of isoproterenol-stimulated phosphorylase a formation in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):326-32. PubMed ID: 6262483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of (-)-norepinephrine and of (+/-)-isoproterenol on cardiac contraction, an uptake phenomenon.
    Korth M; Schmied R
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1164-71. PubMed ID: 2849663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.
    Endoh M
    Eur J Pharmacol; 2004 Oct; 500(1-3):73-86. PubMed ID: 15464022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine, cyclic AMP, calcium, and myocardial contractility.
    Williamson JR; Schaffer S
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():205-23. PubMed ID: 176696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of ketamine on inotropic and chronotropic responsiveness of heart muscle.
    Adams HR; Parker JL; Mathew BP
    J Pharmacol Exp Ther; 1977 Apr; 201(1):171-83. PubMed ID: 191593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between inotropic response and cyclic AMP production induced by isoprenaline and forskolin in rat ventricle strips.
    Martinez E; Fuentes T; Collado MC; Hernández J
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):157-67. PubMed ID: 9226750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge.
    Kobayashi M; Nakamura H; Kobayashi J; Ohizumi Y
    J Pharmacol Exp Ther; 1991 Apr; 257(1):82-9. PubMed ID: 1850480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
    Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
    J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M; Yamashita S; Taira N
    J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326).
    Hayes JS; Bowling N; Pollock GD; Robertson DW
    J Pharmacol Exp Ther; 1986 Apr; 237(1):18-24. PubMed ID: 3007737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca++ inhibition of isoproterenol responses in mammalian skeletal muscle.
    Gross SR; Kelly M
    J Pharmacol Exp Ther; 1981 May; 217(2):271-7. PubMed ID: 6262481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo myocardial effects of a cyclic AMP phosphodiesterase inhibitor structurally related to natural cardenolides.
    Prigent AF; Nemoz G; Roche M; Pacheco H
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):131-52. PubMed ID: 230791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and inotropic effects of verapamil in perfused rat heart.
    Hess ME; Shanfeld J; Levine NR
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():81-8. PubMed ID: 174169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between adenosine 3',5'-monophosphate levels and systolic transmembrane calcium flux.
    Watanabe AM; Besch HR
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():95-102. PubMed ID: 171711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N
    Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.